Naidoo, SanushkaGitaka, JesseSuliman, SaraBaptista, SaraOyedemi, Blessing MbabieNepolo, EmmanuelEnany, Shymaa2022-07-202022-07-202022-01Naidoo, S., Gitaka, J., Suliman., et al. 2022, 'Coronavirus Disease 2019 Diagnostics: Key to Africa’s Recovery', DNA and Cell Biology, vol. 41, no. 1, pp. 30–33, doi : 10.1089/dna.2021.0540.1044-5498 (print)1557-7430 (online)10.1089/dna.2021.0540https://repository.up.ac.za/handle/2263/86331With the coronavirus disease of 2019 (COVID-19) becoming a full-blown outbreak in Africa, coupled with many other challenges faced on the African continent, it is apparent that Africa continues to need diagnostics to enable case identification and recovery to this and future challenges. With the slow vaccination rates across the continent, reliable diagnostic tests will be in demand, likely for years to come. Thus, access to reliable diagnostic tools to detect the severe acute respiratory syndrome of the coronavirus-2 (SARS-CoV-2), the virus responsible for COVID-19, remain a critical pillar to monitor and contain new waves of COVID-19. Increasing the local capacity to manufacture and roll-out vaccines and decentralized COVID-19 testing are paramount for fighting the pandemic in Africa.en© Sanushka Naidoo et al. 2021; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License [CC-BY].DiagnosisCOVID-19 pandemicCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)AfricaReverse transcription-polymerase chain reaction (RT-PCR)Article